PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS
Clinical trials for PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS trials appear
Sign up with your email to follow new studies for PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough heart stent that dissolves
Disease control Not yet recruitingThis study aims to see if a new type of heart stent called Freesolve is as safe and effective as a standard metal stent (Xience). Freesolve is made of magnesium and is designed to dissolve in the artery over time. The study will involve about 1,859 adults with clogged heart arter…
Matched conditions: PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS
Phase: NA • Sponsor: Teleflex • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test if a natural hormone is the hidden culprit behind head injury headaches
Knowledge-focused Not yet recruitingThis study aims to understand what causes headaches after a mild head injury. Researchers will give a hormone-like substance called pramlintide to 21 people with long-term post-traumatic headaches to see if it triggers their migraine-like pain. The goal is to learn more about the…
Matched conditions: PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS
Phase: NA • Sponsor: Danish Headache Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test drug to deliberately trigger migraines
Knowledge-focused Not yet recruitingThis study aims to understand what causes migraines by testing if a hormone-like drug called pramlintide can trigger a migraine attack. Researchers will give the drug or a placebo to 21 adults with migraine without aura and watch for 12 hours to see if a migraine starts. The goal…
Matched conditions: PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS
Phase: NA • Sponsor: Danish Headache Center • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:55 UTC